BiotechTube
Home/Active Biotech/Erik Vahtola
EV

Erik Vahtola

Chief Medical Officer

Active Biotech

Therapeutic Areas

OncologyOphthalmology

Active Biotech Pipeline

DrugIndicationPhase
TasquinimodMyelofibrosisPhase Ib/IIa
Laquinimod (eye drops)Inflammatory Eye Diseases (e.g., Uveitis)Phase I
NaptumomabSolid Tumors (combo with durvalumab)Phase Ib/II

Leadership Team at Active Biotech

HT
Helén Tuvesson
President & CEO
HK
Hans Kolam
Chief Financial Officer
MS
Michael Shalmi
Chairman of the Board
AD
Aleksandar Danilovski
Board Member
AG
Axel Glasmacher
Board Member
UH
Uli Hacksell
Board Member
PT
Peter Thelin
Board Member
View full Active Biotech profile